Febuxostat Therapy for Patients with Gout and Stage 2–4 CKD: a Retrospective Study

INTRODUCTION: The aim of this study is to explore the efficacy and renal safety of febuxostat in gout and stage 2–4 chronic kidney disease (CKD) and factors that correlated with target serum urate (SU). METHODS: A single-center retrospective study including male patients with gout and CKD was conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Peiyu, Chen, Mo, Wang, Jundi, Hu, Shunjie, Lu, Xiaoyong, Wu, Huaxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510076/
https://www.ncbi.nlm.nih.gov/pubmed/36057763
http://dx.doi.org/10.1007/s40744-022-00480-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510076/
https://www.ncbi.nlm.nih.gov/pubmed/36057763
http://dx.doi.org/10.1007/s40744-022-00480-7

Ejemplares similares